Skip to main content
Top
Published in: Antimicrobial Resistance & Infection Control 1/2020

Open Access 01-12-2020 | Radioimmunotherapy | Review

Treating infections with ionizing radiation: a historical perspective and emerging techniques

Authors: B. van Dijk, J. V. C. Lemans, R. M. Hoogendoorn, E. Dadachova, J. M. H. de Klerk, H. C. Vogely, H. Weinans, M. G. E. H. Lam, B. C. H. van der Wal

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2020

Login to get access

Abstract

Background

Widespread use and misuse of antibiotics have led to a dramatic increase in the emergence of antibiotic resistant bacteria, while the discovery and development of new antibiotics is declining. This has made certain implant-associated infections such as periprosthetic joint infections, where a biofilm is formed, very difficult to treat. Alternative treatment modalities are needed to treat these types of infections in the future. One candidate that has been used extensively in the past, is the use of ionizing radiation. This review aims to provide a historical overview and future perspective of radiation therapy in infectious diseases with a focus on orthopedic infections.

Methods

A systematic search strategy was designed to select studies that used radiation as treatment for bacterial or fungal infections. A total of 216 potentially relevant full-text publications were independently reviewed, of which 182 focused on external radiation and 34 on internal radiation. Due to the large number of studies, several topics were chosen. The main advantages, disadvantages, limitations, and implications of radiation treatment for infections were discussed.

Results

In the pre-antibiotic era, high mortality rates were seen in different infections such as pneumonia, gas gangrene and otitis media. In some cases, external radiation therapy decreased the mortality significantly but long-term follow-up of the patients was often not performed so long term radiation effects, as well as potential increased risk of malignancies could not be investigated. Internal radiation using alpha and beta emitting radionuclides show great promise in treating fungal and bacterial infections when combined with selective targeting through antibodies, thus minimizing possible collateral damage to healthy tissue.

Conclusion

The novel prospects of radiation treatment strategies against planktonic and biofilm-related microbial infections seem feasible and are worth investigating further. However, potential risks involving radiation treatment must be considered in each individual patient.
Appendix
Available only for authorised users
Literature
1.
go back to reference Levy SB, Bonnie M. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med. 2004;10(12S):S122–9.PubMedCrossRef Levy SB, Bonnie M. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med. 2004;10(12S):S122–9.PubMedCrossRef
2.
go back to reference Parvizi J, Bs CJ. Definition of Periprosthetic Joint Infection Is There a Consensus ? 2011. p. 3022–30. Parvizi J, Bs CJ. Definition of Periprosthetic Joint Infection Is There a Consensus ? 2011. p. 3022–30.
4.
go back to reference Zmistowski B, Karam JA, Durinka JB, Casper DS, Parvizi J. Periprosthetic joint infection increases the risk of one-year mortality. J Bone Joint Surg Am. 2013;95:2177–84.PubMedCrossRef Zmistowski B, Karam JA, Durinka JB, Casper DS, Parvizi J. Periprosthetic joint infection increases the risk of one-year mortality. J Bone Joint Surg Am. 2013;95:2177–84.PubMedCrossRef
6.
go back to reference Lagendijk JJW, Raaymakers BW, Raaijmakers AJE, et al. MRI/linac integration. Radiother Oncol. 2008;86(1):25–9.PubMedCrossRef Lagendijk JJW, Raaymakers BW, Raaijmakers AJE, et al. MRI/linac integration. Radiother Oncol. 2008;86(1):25–9.PubMedCrossRef
8.
go back to reference Helal M, Dadachova E. Radioimmunotherapy as a novel approach in HIV, bacterial, and fungal infectious diseases. Cancer Biother Radiopharm. 2018;33(8):1–6. Helal M, Dadachova E. Radioimmunotherapy as a novel approach in HIV, bacterial, and fungal infectious diseases. Cancer Biother Radiopharm. 2018;33(8):1–6.
10.
go back to reference Musser JH, Edsall DL. A study of metabolism in leukemia, under the influence of the x-ray. With a consideration of the manner of action of the x-ray and of some precautions desirable in its therapeutic use. Transact Assoc Am Phys. 1905;20:294. Musser JH, Edsall DL. A study of metabolism in leukemia, under the influence of the x-ray. With a consideration of the manner of action of the x-ray and of some precautions desirable in its therapeutic use. Transact Assoc Am Phys. 1905;20:294.
11.
go back to reference Quimby AJ, Quimby WA. Unresolved pneumonia: successful treatment by Röngen ray: AR Elliott; 1916. Quimby AJ, Quimby WA. Unresolved pneumonia: successful treatment by Röngen ray: AR Elliott; 1916.
12.
go back to reference Fried C. Die Röntgentherapie der bronchopneumonia unter besonderer berucksichtigung der bronchopneumonia des kindesalters. Monatsschrift Kinderheilkunde. 1928;38:158. Fried C. Die Röntgentherapie der bronchopneumonia unter besonderer berucksichtigung der bronchopneumonia des kindesalters. Monatsschrift Kinderheilkunde. 1928;38:158.
13.
go back to reference Krost GN. Unresolved pneumonia in children: treatment with roentgen ray. Am J Dis Child. 1925;30:57–71.CrossRef Krost GN. Unresolved pneumonia in children: treatment with roentgen ray. Am J Dis Child. 1925;30:57–71.CrossRef
14.
go back to reference Powell EV. Roentgen therapy of lobar pneumonia. J Am Med Assoc. 1938;110:19–22.CrossRef Powell EV. Roentgen therapy of lobar pneumonia. J Am Med Assoc. 1938;110:19–22.CrossRef
15.
go back to reference Rousseau J, Johnson W, Harrell GT. The value of roentgen therapy in pneumonia which fails to respond to the sulfonamides. Radiology. 1942;38:281–9.CrossRef Rousseau J, Johnson W, Harrell GT. The value of roentgen therapy in pneumonia which fails to respond to the sulfonamides. Radiology. 1942;38:281–9.CrossRef
16.
go back to reference Oppenheimer A. Roentgen therapy of interstitial pneumonia. J Pediatr. 1943;23:534–8.CrossRef Oppenheimer A. Roentgen therapy of interstitial pneumonia. J Pediatr. 1943;23:534–8.CrossRef
17.
go back to reference Chamberlain WE. Roentgen therapy with very small doses: experience in lymphadenitis, leukemia, Hodgkin's disease and certain infections. Acta Radiol. 1926;6:271–80.CrossRef Chamberlain WE. Roentgen therapy with very small doses: experience in lymphadenitis, leukemia, Hodgkin's disease and certain infections. Acta Radiol. 1926;6:271–80.CrossRef
18.
go back to reference Calabrese EJ, Dhawan G. How radiotherapy was historically used to treat pneumonia: could it be useful today? Yale J Biol Med. 2013;86:555–70.PubMedPubMedCentral Calabrese EJ, Dhawan G. How radiotherapy was historically used to treat pneumonia: could it be useful today? Yale J Biol Med. 2013;86:555–70.PubMedPubMedCentral
20.
go back to reference Kelly JF, Dowell DA. Twelve-year review of x-ray therapy of gas gangrene. Radiology. 1941;37:421–39.CrossRef Kelly JF, Dowell DA. Twelve-year review of x-ray therapy of gas gangrene. Radiology. 1941;37:421–39.CrossRef
21.
go back to reference Kelly JF. The X-ray as an aid in the treatment of gas gangrene: Bacillus welchii infection—preliminary report. Radiology. 1933;20:296–304.CrossRef Kelly JF. The X-ray as an aid in the treatment of gas gangrene: Bacillus welchii infection—preliminary report. Radiology. 1933;20:296–304.CrossRef
22.
go back to reference Taliaferro WH, Taliaferro LG. Effect of x-rays on immunity; a review. J Immunol. 1951;66:181–212.PubMed Taliaferro WH, Taliaferro LG. Effect of x-rays on immunity; a review. J Immunol. 1951;66:181–212.PubMed
23.
go back to reference Pendergrass E, Hodes P, Griffith J. Effect of roentgen rays on the minute vessels of the skin in man. Amer J Roent. 1944;52:123–7. Pendergrass E, Hodes P, Griffith J. Effect of roentgen rays on the minute vessels of the skin in man. Amer J Roent. 1944;52:123–7.
24.
go back to reference Coleman E, Bennett D. Personal experiences with gas bacillus infection: a report of forty-one cases. Am J Surg. 1939;43:77–80.CrossRef Coleman E, Bennett D. Personal experiences with gas bacillus infection: a report of forty-one cases. Am J Surg. 1939;43:77–80.CrossRef
25.
go back to reference Calabrese EJ, Dhawan G. The role of x-rays in the treatment of gas gangrene: a historical assessment. Dose Response. 2012;10:626–43.PubMedPubMedCentral Calabrese EJ, Dhawan G. The role of x-rays in the treatment of gas gangrene: a historical assessment. Dose Response. 2012;10:626–43.PubMedPubMedCentral
26.
go back to reference Coyle RR. Odd and ends of x-ray work, including some cases of carbuncle. Med Electrol Radiol. 1906;7(1):39–142. Coyle RR. Odd and ends of x-ray work, including some cases of carbuncle. Med Electrol Radiol. 1906;7(1):39–142.
27.
go back to reference Dunham K. Treatment of carbuncles by the roentgen ray. Am J Roentgenol. 1916;3:259–60. Dunham K. Treatment of carbuncles by the roentgen ray. Am J Roentgenol. 1916;3:259–60.
28.
go back to reference Desjardins AU. Radiotherapy for inflammatory conditions. J Am Med Assoc. 1931;96:401–8.CrossRef Desjardins AU. Radiotherapy for inflammatory conditions. J Am Med Assoc. 1931;96:401–8.CrossRef
29.
go back to reference Calabrese EJ. X-ray treatment of carbuncles and furuncles (boils): a historical assessment. Hum Exp Toxicol. 2013;32(8):817–27.PubMedCrossRef Calabrese EJ. X-ray treatment of carbuncles and furuncles (boils): a historical assessment. Hum Exp Toxicol. 2013;32(8):817–27.PubMedCrossRef
30.
go back to reference Bluestone CD. Pathogenesis of otitis media: role of eustachian tube. Pediatr Infect Dis J. 1996;15:281–91.PubMedCrossRef Bluestone CD. Pathogenesis of otitis media: role of eustachian tube. Pediatr Infect Dis J. 1996;15:281–91.PubMedCrossRef
31.
go back to reference Radioactieve stoffenbesluit (Warenwet). Staatsblad van het Koninkrijk der Nederlanden. 1958. Stb; 1958. p. 317. Radioactieve stoffenbesluit (Warenwet). Staatsblad van het Koninkrijk der Nederlanden. 1958. Stb; 1958. p. 317.
32.
go back to reference Heineke H. Experimentelle Untersuchungen über die Einwirkung der Röntgenstrahlen auf innere Organe. Mitt Grenzgeb Med Chir. 1905;14:21. Heineke H. Experimentelle Untersuchungen über die Einwirkung der Röntgenstrahlen auf innere Organe. Mitt Grenzgeb Med Chir. 1905;14:21.
33.
go back to reference Beattie R. Treatment of subacute and chronic otitis media with use of X-ray. J Mich St Med Soc. 1921;20:449–51. Beattie R. Treatment of subacute and chronic otitis media with use of X-ray. J Mich St Med Soc. 1921;20:449–51.
34.
go back to reference Calabrese E, Dhawan G. Historical use of x-rays: treatment of inner ear infections and prevention of deafness. Hum Exp Toxicol. 2014;33:542–53.PubMedCrossRef Calabrese E, Dhawan G. Historical use of x-rays: treatment of inner ear infections and prevention of deafness. Hum Exp Toxicol. 2014;33:542–53.PubMedCrossRef
35.
go back to reference Crowe SJ, Baylor JW. The prevention of deafness. J Am Med Assoc. 1939;112:585–90.CrossRef Crowe SJ, Baylor JW. The prevention of deafness. J Am Med Assoc. 1939;112:585–90.CrossRef
36.
go back to reference Crowe SJ, Walzl EM. Irradiation of hyperplastic lymphoid tissue in the Nasopharynx. J Am Med Assoc. 1947;134:124–7.PubMedCrossRef Crowe SJ, Walzl EM. Irradiation of hyperplastic lymphoid tissue in the Nasopharynx. J Am Med Assoc. 1947;134:124–7.PubMedCrossRef
37.
go back to reference Verduijn PG, Hayes RB, Looman C, Habbema JD, van der Maas PJ. Mortality after nasopharyngeal radium irradiation for eustachian tube dysfunction. Ann Otol Rhinol Laryngol. 1989;98:839–44.PubMedCrossRef Verduijn PG, Hayes RB, Looman C, Habbema JD, van der Maas PJ. Mortality after nasopharyngeal radium irradiation for eustachian tube dysfunction. Ann Otol Rhinol Laryngol. 1989;98:839–44.PubMedCrossRef
38.
go back to reference Ronckers CM, Van Leeuwen FE, Hayes RB, Verduijn PG, Stovall M, et al. Cancer incidence after nasopharyngeal radium irradiation. Epidemiology. 2002;13:552–60.PubMedCrossRef Ronckers CM, Van Leeuwen FE, Hayes RB, Verduijn PG, Stovall M, et al. Cancer incidence after nasopharyngeal radium irradiation. Epidemiology. 2002;13:552–60.PubMedCrossRef
39.
40.
go back to reference Hardy WG, Bordley JE. Observations from a controlled study on the effect of nasopharyngeal irradiation in a group of school age children. Ann Otol Rhinol Laryngol. 1954;63:816–26.PubMedCrossRef Hardy WG, Bordley JE. Observations from a controlled study on the effect of nasopharyngeal irradiation in a group of school age children. Ann Otol Rhinol Laryngol. 1954;63:816–26.PubMedCrossRef
41.
go back to reference Schneider AB, Lubin J, Ron E, Abrahams C, Stovall M, et al. Salivary gland tumors after childhood radiation treatment for benign conditions of the head and neck: dose-response relationships. Radiat Res. 1998;149:625–30.PubMedCrossRef Schneider AB, Lubin J, Ron E, Abrahams C, Stovall M, et al. Salivary gland tumors after childhood radiation treatment for benign conditions of the head and neck: dose-response relationships. Radiat Res. 1998;149:625–30.PubMedCrossRef
42.
go back to reference Sandler DP, Comstock GW, Matanoski GM. Neoplasms following childhood radium irradiation of the nasopharynx. J Natl Cancer Inst. 1982;68:3–8.PubMed Sandler DP, Comstock GW, Matanoski GM. Neoplasms following childhood radium irradiation of the nasopharynx. J Natl Cancer Inst. 1982;68:3–8.PubMed
43.
go back to reference Yeh H, Matanoski GM, Wang N, Sandler DP, Comstock GW. Cancer incidence after childhood nasopharyngeal radium irradiation: a follow-up study in Washington County. Maryland Am J Epidemiol. 2001;153:749–56.PubMedCrossRef Yeh H, Matanoski GM, Wang N, Sandler DP, Comstock GW. Cancer incidence after childhood nasopharyngeal radium irradiation: a follow-up study in Washington County. Maryland Am J Epidemiol. 2001;153:749–56.PubMedCrossRef
44.
45.
go back to reference Graamans K. Nasopharyngeal radium irradiation: the lessons of history. Int J Pediatr Otorhinolaryngol. 2017;93:53–62.PubMedCrossRef Graamans K. Nasopharyngeal radium irradiation: the lessons of history. Int J Pediatr Otorhinolaryngol. 2017;93:53–62.PubMedCrossRef
46.
go back to reference Strebhardt K, Ullrich A. Strebhardt & Ulrich 2008 Paul Ehrlichs magic bullet concept. Nat Rev Cancer. 2008;8(june):473–80.PubMedCrossRef Strebhardt K, Ullrich A. Strebhardt & Ulrich 2008 Paul Ehrlichs magic bullet concept. Nat Rev Cancer. 2008;8(june):473–80.PubMedCrossRef
47.
go back to reference Spiess H. Peteosthor – a medical disaster due to Radium-224; 2002. p. 163–72. Spiess H. Peteosthor – a medical disaster due to Radium-224; 2002. p. 163–72.
48.
go back to reference Wick RR, Gossner W. History and current uses of 224 Ra in ankylosing spondylitis and other diseases. Environ Int. 1993;19:467–73. Wick RR, Gossner W. History and current uses of 224 Ra in ankylosing spondylitis and other diseases. Environ Int. 1993;19:467–73.
49.
go back to reference Tomb JF, White O, Kerlavage AR, Al E, Tomb J-F, et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature. 1997;388(September):539–47.PubMedCrossRef Tomb JF, White O, Kerlavage AR, Al E, Tomb J-F, et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature. 1997;388(September):539–47.PubMedCrossRef
50.
go back to reference Gholamrezanezhad A, Mirpour S, Saghari M, Abdollahzadeh J, Pourmoslemi A, Yarmand S. Radio-iodine therapy and helicobacter pylori infection. Ann Nucl Med. 2008;22(10):917–20.PubMedCrossRef Gholamrezanezhad A, Mirpour S, Saghari M, Abdollahzadeh J, Pourmoslemi A, Yarmand S. Radio-iodine therapy and helicobacter pylori infection. Ann Nucl Med. 2008;22(10):917–20.PubMedCrossRef
51.
go back to reference Arduc A, Dogan BA, Ozuguz U, et al. The effect of radioactive iodine treatment on 14C urea breath test results in patients with hyperthyroidism. Clin Nucl Med. 2014;39(12):1022–6.PubMedCrossRef Arduc A, Dogan BA, Ozuguz U, et al. The effect of radioactive iodine treatment on 14C urea breath test results in patients with hyperthyroidism. Clin Nucl Med. 2014;39(12):1022–6.PubMedCrossRef
52.
go back to reference Shmuely H, Friedman M, Aronov I, et al. The effect of radioiodine on eradication of helicobacter pylori infection in patients with thyroid cancer-a pilot study. Oper Tech Otolaryngol - Head Neck Surg. 2012;23(3):206–10.CrossRef Shmuely H, Friedman M, Aronov I, et al. The effect of radioiodine on eradication of helicobacter pylori infection in patients with thyroid cancer-a pilot study. Oper Tech Otolaryngol - Head Neck Surg. 2012;23(3):206–10.CrossRef
53.
go back to reference Usluogullari CA, Demir OE, Ozdemir E, et al. What is the effect of radioiodine therapy on Helicobacterpylori infection? Turkish J Med Sci. 2014;44(3):520–3.CrossRef Usluogullari CA, Demir OE, Ozdemir E, et al. What is the effect of radioiodine therapy on Helicobacterpylori infection? Turkish J Med Sci. 2014;44(3):520–3.CrossRef
54.
go back to reference Chabner BA, Roberts Jr TGR. Chemotherapy and the War on Cancer. Nature Reviews Cancer. 2005;5(1):65–72. Chabner BA, Roberts Jr TGR. Chemotherapy and the War on Cancer. Nature Reviews Cancer. 2005;5(1):65–72.
55.
go back to reference Joo WD, Visintin I, Mor G, Sciences R, Haven N. Targeted cancer therapy – Are the days of systemic chemotherapy numbered? Maturitas. 2013;76(4):308–14.PubMedPubMedCentralCrossRef Joo WD, Visintin I, Mor G, Sciences R, Haven N. Targeted cancer therapy – Are the days of systemic chemotherapy numbered? Maturitas. 2013;76(4):308–14.PubMedPubMedCentralCrossRef
56.
57.
go back to reference Martinez LR, Bryan RA, Apostolidis C, Morgenstern A, Casadevall A, Dadachova E. Antibody-guided alpha radiation effectively damages fungal biofilms. Antimicrob Agents Chemother. 2006;50(6):2132–6.PubMedPubMedCentralCrossRef Martinez LR, Bryan RA, Apostolidis C, Morgenstern A, Casadevall A, Dadachova E. Antibody-guided alpha radiation effectively damages fungal biofilms. Antimicrob Agents Chemother. 2006;50(6):2132–6.PubMedPubMedCentralCrossRef
58.
go back to reference Dadachova E, Nakouzi A, Bryan RA, Casadevall A. Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection. Proc Natl Acad Sci U S A. 2003;100(19):10942–7.PubMedPubMedCentralCrossRef Dadachova E, Nakouzi A, Bryan RA, Casadevall A. Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection. Proc Natl Acad Sci U S A. 2003;100(19):10942–7.PubMedPubMedCentralCrossRef
59.
go back to reference Bryan RA, Jiang Z, Howell RC, et al. Radioimmunotherapy is more effective than antifungal treatment in experimental Cryptococcal infection. J Infect Dis. 2010;202(4):633–7.PubMedCrossRef Bryan RA, Jiang Z, Howell RC, et al. Radioimmunotherapy is more effective than antifungal treatment in experimental Cryptococcal infection. J Infect Dis. 2010;202(4):633–7.PubMedCrossRef
60.
go back to reference Dadachova E, Burns T, Bryan RA, et al. Feasibility of radioimmunotherapy of experimental pneumococcal infection. Antimicrob Agents Chemother. 2004;48(5):1624–9.PubMedPubMedCentralCrossRef Dadachova E, Burns T, Bryan RA, et al. Feasibility of radioimmunotherapy of experimental pneumococcal infection. Antimicrob Agents Chemother. 2004;48(5):1624–9.PubMedPubMedCentralCrossRef
61.
go back to reference Rivera J, Nakouzi AS, Morgenstern A, Bruchertseifer F, Dadachova E, Casadevall A. Radiolabeled antibodies to Bacillus anthracis toxins are bactericidal and partially therapeutic in experimental murine anthrax. Antimicrob Agents Chemother. 2009;53(11):4860–8.PubMedPubMedCentralCrossRef Rivera J, Nakouzi AS, Morgenstern A, Bruchertseifer F, Dadachova E, Casadevall A. Radiolabeled antibodies to Bacillus anthracis toxins are bactericidal and partially therapeutic in experimental murine anthrax. Antimicrob Agents Chemother. 2009;53(11):4860–8.PubMedPubMedCentralCrossRef
62.
go back to reference Tietz CJ, Spiess H. Über die Hemmwirkung des Peteosthor und seiner Komponenten auf das Wachstum humaner Tuberkelbakterien in vitro. In: Klinische Wochenschrift; 1950. Tietz CJ, Spiess H. Über die Hemmwirkung des Peteosthor und seiner Komponenten auf das Wachstum humaner Tuberkelbakterien in vitro. In: Klinische Wochenschrift; 1950.
63.
go back to reference Bannas P, Hambach J, Koch-Nolte F. Nanobodies and nanobody-based human heavy chain antibodies as antitumor therapeutics. Front Immunol. 2017;8(NOV):1–13. Bannas P, Hambach J, Koch-Nolte F. Nanobodies and nanobody-based human heavy chain antibodies as antitumor therapeutics. Front Immunol. 2017;8(NOV):1–13.
64.
go back to reference Parker C, Nilsson S, Heinrich D, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med. 2013;369(3):213–23.PubMedCrossRef Parker C, Nilsson S, Heinrich D, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med. 2013;369(3):213–23.PubMedCrossRef
65.
go back to reference Ter Heine R, Lange R, Breukels OB, et al. Bench to bedside development of GMP grade Rhenium-188-HEDP, a radiopharmaceutical for targeted treatment of painful bone metastases. Int J Pharm. 2014;465(1–2):317–24.PubMedCrossRef Ter Heine R, Lange R, Breukels OB, et al. Bench to bedside development of GMP grade Rhenium-188-HEDP, a radiopharmaceutical for targeted treatment of painful bone metastases. Int J Pharm. 2014;465(1–2):317–24.PubMedCrossRef
Metadata
Title
Treating infections with ionizing radiation: a historical perspective and emerging techniques
Authors
B. van Dijk
J. V. C. Lemans
R. M. Hoogendoorn
E. Dadachova
J. M. H. de Klerk
H. C. Vogely
H. Weinans
M. G. E. H. Lam
B. C. H. van der Wal
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Antimicrobial Resistance & Infection Control / Issue 1/2020
Electronic ISSN: 2047-2994
DOI
https://doi.org/10.1186/s13756-020-00775-w

Other articles of this Issue 1/2020

Antimicrobial Resistance & Infection Control 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.